Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT

Clinical trial NCT06551584 · RECRUITING

Trial details

NCT number: NCT06551584
Sponsor: Stanford University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Acute Lymphoid Leukemia Mixed Phenotype Acute Leukemia Myelodysplastic Syndromes

Start date: 2025-12-01
Primary completion: 2026-12-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.